Artificial intelligence in the diagnosis and management of hepatocellular carcinoma
- PMID: 33709610
- DOI: 10.1111/jgh.15413
Artificial intelligence in the diagnosis and management of hepatocellular carcinoma
Abstract
Despite recent improvements in therapeutic interventions, hepatocellular carcinoma is still associated with a poor prognosis in patients with an advanced disease at diagnosis. Recently, significant progress has been made in image recognition through advances in the field of artificial intelligence (AI) (or machine learning), especially deep learning. AI is a multidisciplinary field that draws on the fields of computer science and mathematics for developing and implementing computer algorithms capable of maximizing the predictive accuracy from static or dynamic data sources using analytic or probabilistic models. Because of the multifactorial and complex nature of liver diseases, the machine learning approach to integrate multiple factors would appear to be an advantageous approach to improve the likelihood of making a precise diagnosis and predicting the response of treatment and prognosis of liver diseases. In this review, we attempted to summarize the potential use of AI in the diagnosis and management of liver diseases, especially hepatocellular carcinoma.
Keywords: artificial intelligence; deep learning; hepatocellular carcinoma; machine learning; predictive model.
© 2021 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.
Similar articles
-
Application of artificial intelligence in the diagnosis and treatment of hepatocellular carcinoma: A review.World J Gastroenterol. 2020 Oct 7;26(37):5617-5628. doi: 10.3748/wjg.v26.i37.5617. World J Gastroenterol. 2020. PMID: 33088156 Free PMC article. Review.
-
Artificial intelligence in hepatocellular carcinoma diagnosis: a comprehensive review of current literature.J Gastroenterol Hepatol. 2024 Oct;39(10):1994-2005. doi: 10.1111/jgh.16663. Epub 2024 Jun 23. J Gastroenterol Hepatol. 2024. PMID: 38923550 Review.
-
Harnessing the Power of AI for Enhanced Diagnosis and Treatment of Hepatocellular Carcinoma.Turk J Gastroenterol. 2024 Dec 16;36(4):200-208. doi: 10.5152/tjg.2024.24325. Turk J Gastroenterol. 2024. PMID: 39714118 Free PMC article. Review.
-
Artificial intelligence for the prevention and clinical management of hepatocellular carcinoma.J Hepatol. 2022 Jun;76(6):1348-1361. doi: 10.1016/j.jhep.2022.01.014. J Hepatol. 2022. PMID: 35589255 Free PMC article. Review.
-
Prognostic role of artificial intelligence among patients with hepatocellular cancer: A systematic review.World J Gastroenterol. 2020 Nov 14;26(42):6679-6688. doi: 10.3748/wjg.v26.i42.6679. World J Gastroenterol. 2020. PMID: 33268955 Free PMC article.
Cited by
-
Predicting synkinesis caused by Bell's palsy or Ramsay Hunt syndrome using machine learning-based logistic regression.Laryngoscope Investig Otolaryngol. 2023 Aug 25;8(5):1189-1195. doi: 10.1002/lio2.1145. eCollection 2023 Oct. Laryngoscope Investig Otolaryngol. 2023. PMID: 37899861 Free PMC article.
-
Multiphase Computed Tomography Scan Findings for Artificial Intelligence Training in the Differentiation of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma Based on Interobserver Agreement of Expert Abdominal Radiologists.Diagnostics (Basel). 2025 Mar 24;15(7):821. doi: 10.3390/diagnostics15070821. Diagnostics (Basel). 2025. PMID: 40218171 Free PMC article.
-
Implementation of resource-efficient fetal echocardiography detection algorithms in edge computing.PLoS One. 2024 Sep 23;19(9):e0305250. doi: 10.1371/journal.pone.0305250. eCollection 2024. PLoS One. 2024. PMID: 39312521 Free PMC article.
-
Long non-coding RNA LOC107985656 represses the proliferation of hepatocellular carcinoma cells through activation of the tumor-suppressive Hippo pathway.Bioengineered. 2021 Dec;12(1):7964-7974. doi: 10.1080/21655979.2021.1984005. Bioengineered. 2021. PMID: 34565286 Free PMC article.
-
Artificial intelligence to predict hepatocellular carcinoma risk in cirrhosis.World J Gastrointest Oncol. 2025 Jun 15;17(6):107414. doi: 10.4251/wjgo.v17.i6.107414. World J Gastrointest Oncol. 2025. PMID: 40547139 Free PMC article. Review.
References
-
- Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J. Clin. 2005; 55: 74-108.
-
- Kudo M, Izumi N, Sakamoto M et al. Survival analysis over 28 years of 173,378 patients with hepatocellular carcinoma in Japan. Liver Cancer 2016; 5: 190-197. https://doi.org/10.1159/000367775
-
- Trevisani F, Cantarini MC, Wands JR, Bernardi M. Recent advances in the natural history of hepatocellular carcinoma. Carcinogenesis 2008; 29: 1299-1305. https://doi.org/10.1093/carcin/bgn113
-
- Krizhevsky A, Sutskever I, Hinton GE. IImagenet classification with deep convolutional neural networks. Adv. Neural. Inform. Process. Syst. 2012; 1097-1105.
-
- Mori Y, Kudo SE, Misawa M et al. Real-time use of artificial intelligence in identification of diminutive polyps during colonoscopy: a prospective study. Ann. Intern. Med. 2018; 169: 357-366. https://doi.org/10.7326/m18-0249
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical